I would have loved to post about EPI-326, the 1st bispecific antibody surface protein degrader in clinics (based on research from Jim Wells’ lab). Unfortunately only a single slide devoid of Do Not Post. Impressive data for an ITGB6-dependent healthy tissue sparing bsAb. #AACR26